Journal Information
Share
Download PDF
More article options
Scientific letter
Caplacizumab in acquired thrombotic thrombocytopenic thrombocytopenic purpura: dose adjustment based on von Willebrand factor level
Caplacizumab en la púrpura trombocitopénica trombótica adquirida: ajuste de la dosis basado en el factor de von Willebrand